GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis

Abstract on the unique private-sector collaboration of the pharmaceutical companies GlaxoSmithKline (GSK) and Merck & Co., Inc., Kenilworth, N.J., U.S.A.,* to support the global efforts to eliminate lymphatic filariasis, through donations of drugs to prevent the disease. Gustavsen, Bradley, and Wright, Annals of Tropical Medicine & Parasitology, Volume 103, 2009 – Issue sup1.

 

*Merck & Co., Inc., Kenilworth, N.J., U.S.A., is known as MSD outside of the United States and Canada.

Share This Post:

Facebook
Twitter
LinkedIn
Email
Print